1-氨甲基-5-甲氧基茚满

  • 未分配
法律規範狀態法律規範
  • 失控
识别信息
  • (5-Methoxy-2,3-dihydro-1H-inden-1-yl)methanamine
CAS号1415750-28-5  ☒NPubChem CID
  • 45091234
ChemSpider
  • 24205063 checkY
UNII
  • 585V6BDH9X
CompTox Dashboard（英语：CompTox Chemicals Dashboard） (EPA)
  • DTXSID801029881 編輯維基數據鏈接
化学信息化学式C11H15NO摩尔质量177.25 g·mol−13D模型（JSmol（英语：JSmol））
  • 交互式图像
  • NCC1CCc2c1ccc(OC)c2
  • InChI=1S/C11H15NO/c1-13-10-4-5-11-8(6-10)2-3-9(11)7-12/h4-6,9H,2-3,7,12H2,1H3 checkY
  • Key:WPBKCMLYKMDWRD-UHFFFAOYSA-N checkY

1-氨甲基-5-甲氧基茚满（英语：1-Aminomethyl-5-methoxyindane，简称AMMI），是一种由普渡大学的大卫·厄尔·尼科尔斯领导的团队开发的药物，它作为选择性血清素释放剂并与和DiFMDA具有相似亲和力的血清素转运蛋白结合。[1][2]

参见

  • 2CB-Ind

参考资料

  1. ^ Roman DL, Saldaña SN, Nichols DE, Carroll FI, Barker EL. Distinct molecular recognition of psychostimulants by human and Drosophila serotonin transporters. The Journal of Pharmacology and Experimental Therapeutics. February 2004, 308 (2): 679–87. PMID 14593087. S2CID 6439942. doi:10.1124/jpet.103.057836. 
  2. ^ Walline CC, Nichols DE, Carroll FI, Barker EL. Comparative molecular field analysis using selectivity fields reveals residues in the third transmembrane helix of the serotonin transporter associated with substrate and antagonist recognition. The Journal of Pharmacology and Experimental Therapeutics. June 2008, 325 (3): 791–800. PMC 2637348 可免费查阅. PMID 18354055. doi:10.1124/jpet.108.136200.